Track topics on Twitter Track topics that are important to you
Founded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on the development of next-generation multi-specific antibodies. The company uses proprietary patented technology to engineer single molecular entities that may interact with two or more targets. The company will initially focus its Zybody(TM) development on therapies for various cancers and autoimmune disorders. Zyngenia is headquartered in Rockville, Maryland. For more information, visit www.zyngenia.com.
Founded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on the development of next-generation multi-specific antibodies. The company uses proprietary patented technology to...
We have published hundreds of Zyngenia, Inc. news stories on BioPortfolio along with dozens of Zyngenia, Inc. Clinical Trials and PubMed Articles about Zyngenia, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zyngenia, Inc. Companies in our database. You can also find out about relevant Zyngenia, Inc. Drugs and Medications on this site too.
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...